LifeMD Inc. (NASDAQ: LFMD) is 144.72% higher on its value in year-to-date trading and has touched a low of $0.99 and a high of $33.02 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LFMD stock was last observed hovering at around $18.87 in the last trading session, with the day’s loss setting it -2.89% off its average median price target of $37.50 for the next 12 months. It is also 60.05% off the consensus price target high of $40.00 offered by 2 analysts, but current levels are 54.34% higher than the price target low of $35.00 for the same period.
Currently trading at $15.98, the stock is -12.81% and -20.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing -15.32% at the moment leaves the stock 67.99% off its SMA200. LFMD registered 1231.67% gain for a year compared to 6-month gain of 121.94%. The firm has a 50-day simple moving average (SMA 50) of $21.77 and a 200-day simple moving average (SMA200) of $11.74.
The stock witnessed a -25.01% loss in the last 1 month and extending the period to 3 months gives it a 119.81%, and is -19.37% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.35% over the week and 14.11% over the month.
LifeMD Inc. (LFMD) has around 3 employees, a market worth around $366.90M and $28.30M in sales. Distance from 52-week low is 1508.05% and -51.61% from its 52-week high. The company has generated returns on investments over the last 12 months (1383.60%).
LifeMD Inc. (LFMD) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for LifeMD Inc. (LFMD) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
LifeMD Inc. is expected to release its quarterly report on 05/18/2021 and quarterly earnings per share for the current quarter are estimated at -$0.21 with sales reaching $15.85M over the same period.The EPS is expected to shrink by -29.30% this year, but quarterly earnings will post 102.00% year-over-year.
LifeMD Inc. (LFMD) Top Institutional Holders
17 institutions hold shares in LifeMD Inc. (LFMD), with 7.59M shares held by insiders accounting for 38.67% while institutional investors hold 6.24% of the company’s shares. The shares outstanding are 25.58M, and float is at 12.07M with Short Float at 5.95%. Institutions hold 3.83% of the Float.
The top institutional shareholder in the company is Monashee Investment Management LLC with over 0.42 million shares valued at $2.75 million. The investor’s holdings represent 1.82% of the LFMD Shares outstanding. As of Dec 30, 2020, the second largest holder is G2 Investment Partners Management LLC with 0.23 million shares valued at $1.53 million to account for 1.01% of the shares outstanding. The other top investors are Barry Investment Advisors, LLC which holds 83200.0 shares representing 0.36% and valued at over $0.54 million, while Magnus Financial Group LLC holds 0.20% of the shares totaling 47490.0 with a market value of $0.31 million.
LifeMD Inc. (LFMD) Insider Activity
A total of 11 insider transactions have happened at LifeMD Inc. (LFMD) in the last six months, with sales accounting for 1 and purchases happening 10 times.